Table 1.
Unit: mg | Children | Adolescents | Adults | |||
---|---|---|---|---|---|---|
VO2net | MET | VO2net | MET | VO2net | MET | |
Hip placement | ||||||
Light | 29 | 52 | 32 | 50 | 39 | 39 |
Moderate | 124 | 214 | 157 | 219 | 167 | 167 |
Vigorous | 368 | 704 | 482 | 753 | 582 | 582 |
Very vigorous | 695 | 1075 | 830 | 1062 | 994 | 994 |
R2 = 0.96 | R2 = 0.96 | R2 = 0.97 | R2 = 0.98 | R2 = 0.98 | R2 = 0.98 | |
Thigh placement | ||||||
Light | 60 | 99 | 63 | 90 | 67 | 67 |
Moderate | 234 | 380 | 274 | 368 | 273 | 273 |
Vigorous | 603 | 987 | 700 | 964 | 782 | 782 |
Very vigorous | 964 | 1312 | 1034 | 1272 | 1181 | 1181 |
R2 = 0.93 | R2 = 0.95 | R2 = 0.95 | R2 = 0.98 | R2 = 0.98 | R2 = 0.98 |
Children 9–11, adolescents 14–16 and adults 23–44 years old. VO2net cut-points (mL⋅min−1⋅kg−1): LPA 1.1, MPA 5.5, VPA 14.2 and VVPA 22.9. MET cut-points (METs): LPA 1.5, MPA 3.0, VPA 6.0 and VVPA 9.0. Explained variation (R2) is presented for the fit of the regression line between VO2net/MET and accelerometer mg.